In pharma, the brands that win don't wait for the market to define them. They define themselves through clear, early, and evolving positioning.

In this episode, Lumanity's Natalie Thovmasian (Vice President) and Liv Yates (Managing Consultant) make the case that brand positioning isn't a launch checkbox; it's a strategic driver across the entire product lifecycle. Their core argument: shape positioning early, before clinical data lands, by anchoring a bold vision in a target product profile, real customer needs, and where the market is heading next.

Natalie and Liv unpack why strong positioning works as a mental shortcut for buyers, demanding clarity, differentiation, and emotional resonance to cut through the noise of a data-saturated category. And because markets shift, positioning has to be revisited and refined continuously to stay relevant, consistent, and commercially sharp.

A few things you'll take away:

Why positioning belongs in early development, not just launch planning
How a target product profile anchors a bold, differentiated vision
What separates positioning that resonates from positioning that gets ignored
How to evolve positioning as the clinical and competitive landscape shifts

If you're building or scaling a pharma brand, this conversation is essential listening.

Resources:

Connect with and follow Natalie Thovmasian on LinkedIn.
Connect with and follow Liv Yates on LinkedIn.
Learn more about this series we're doing with Lumanity here: https://lumanity.com/commercialization-podcasts/